Abstract PO-007: A Phase 1 Study of Romidepsin, Azacitidine, Dexamethasone, and Lenalidomide (radr) for Relapsed/refractory T-cell Malignancies
Blood Cancer Discovery(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Blood Cancer Discovery(2024)